Cambrex

Reliable manufacturing of drug substances for clinical trials is critical for any pharmaceutical company, but it can be particularly challenging for small and emerging organizations if they lack the in-house expertise, capacity or scale needed as the demand becomes greater in later phases.

...

When it comes to commercial API manufacturing, not all CDMOs are created equal. Manufacturing capacity is important, but so is the mission of the team working on your project. Are they completely invested in your success? Are they prepared to do whatever it takes to address the challenges that will inevita...

API manufacturing is a long journey that requires a forward-looking, scientific approach to ensure smooth transitions as manufacturing requirements increase. The GMP process requires a comprehensive assessment of everything from the starting materials, premises, equipment and quality systems to the trainin...

As generic drug companies work to provide a reliable supply of finished drug products, Cambrex offers a robust library of APIs and intermediates, as well as quality, safety and supply security.

Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical pa...

Ensuring Pharmaceutical Safety and Compliance
Nitrosamines can form during the manufacturing process of active pharmaceutical ingredients (APIs) and drug products. Because of their potential carcinogenic properties, nitrosamine impurities pose significant health risks to patients. Regulatory bodies li...

In pharmaceuticals, peptides are revolutionizing targeted treatments for chronic conditions such as cancer, hormonal disorders and neurodegenerative diseases. Their ability to mimic natural processes makes them highly effective and safe, offering innovative solutions for modern medicines.

As...

Working with Cambrex and Snapdragon Chemistry, our clients benefit from a proactive and phase-appropriate approach to API process development and validation, as well as access to advanced technology and industry-leading expertise in autonomous process development.
We are structured to oversee cust...

Pharmaceutical reference standards are essential for ensuring the quality, safety and efficacy of pharmaceuticals. These meticulously characterized materials serve as benchmarks for analytical testing, enabling manufacturers to verify the identity, purity and potency of active pharmaceutical ingredients (A...

Managing stability storage in-house can be complex, time-consuming, and resource intensive. By outsourcing your stability storage, you can optimise your stability program, reduce staffing and equipment costs, minimise risks associated with outdated equipment or missed stability pulls, and address complianc...

Cambrex announced today that Snapdragon Chemistry, a Cambrex company, has expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts to further support the development and manufacturing of peptide therapies.

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides drug substance, drug product, and analytical services across the entire drug lifecycle. As an innovative life sciences company with a refreshingly human approach to the way we do business, our pharmaceutical products, technologies and expertise help you accelerate your programs through development to market. Our core capabilities include:
Drug substanceDrug productAnalytical testingTo see the full list of comprehensive services, download our company overview brochure.

Cambrex and Snapdragon Chemistry, a Cambrex company, are proud to announce that Dr. Song Lin, Tisch University Professor in chemistry and chemical biology at Cornell University’s College of Arts and Sciences, has been awarded the 2025 Snapdragon Prize for Innovation in Chemistry Technology, which includes a $50,000 unrestricted fund for the Lin Lab.

Cambrex is a leading global contract development and manufacturing organization (CDMO) that provides analytical services across the entire drug lifecycle. You can trust our analytical development and testing experts to rapidly advance your molecule for the greatest chance of success. Our analytical capabilities include:
Method development & validationMaterial characterizationCompendial & release testingStability storage & testingBiopharmaceutical testingMicrobiology & cleanroom servicesImpurity isolation, identification & characterizationReference standard qualificationDownload our analytical capabilities and expertise overview brochure to learn more.

Cambrex announced the completion of initial engineering studies for its new, large-scale active pharmaceutical ingredient (API) manufacturing plant in Charles City, Iowa. This milestone marks significant progress toward the company’s previously announced $120 million investment in expanding its U.S. API manufacturing capabilities. Groundbreaking for the new facility is scheduled to take place in late 2026.

From laboratory scale to commercial supply, you’ll enjoy working with our experts on your API. We have over 40 years of experience serving global clients with drug substance development and manufacturing needs for both custom and generic APIs and intermediates. Our robust services include:
Custom API developmentCustom API manufacturingGeneric API manufacturingSolid state scienceMaterial characterizationWe specialize in complex programs utilizing innovative science and technology like continuous flow to solve complicated problems. We can also work with controlled substances and highly potent APIs. To learn more about our comprehensive drug substance capabilities, download our overview brochure.

After another year of impressive nominations for the CPHI Pharma Awards our winners were announced at CPHI Barcelona in October. In this series of interviews, we speak to the teams behind the award-winning projects, concepts, and technologies. 

Cambrex is a leading global supplier of generic APIs. We work with generic drug companies well in advance of drug patent expiration, using high-quality, non-patent infringing processes to manufacture APIs. We produce over 90 generic APIs, intermediates, derivatives, and chiral compounds, including controlled substances.

To see the complete list of the products we manufacture, download our full product list.

Throughout CPHI North America (Philadelphia, PA; April 25–27, 2023), we caught up with some of the exhibiting organisations to ask what the show brings to the North American pharmaceutical sector, and what is driving industry innovation in this region of the world.    

Discover how Cambrex is shaping the future of pharmaceutical development in our latest video. At Cambrex, scientific innovation is at the heart of everything we do. We continually invest in advanced technologies—including biocatalysis, continuous flow technology, highly potent API manufacturing, reactor design and build, and more —to deliver transformative solutions for our partners and accelerate the path from development through commercialization. Our commitment to pushing the boundaries of what’s possible sets us apart as a leader in the industry.  Join us in celebrating innovation, collaboration, and the relentless pursuit of scientific advancement—watch now and see why Cambrex is your trusted partner in pharmaceutical development.

Check out Snapdragon Chemistry’s new GMP manufacturing suite, which increases the overall facility footprint by 20% and includes an ISO-7 cleanroom for preparative HPLC chromatography and lyophilization, cold storage for raw materials and a product storage suite.